Multiple sclerosis: The frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha

Journal of Neuroimmunology

Volumn 84, Issue 2, 1998, Pages 198-206

  Mycko, M ^a   Kowalski, W ^b   Kwinkowski, M ^a   Buenafe, A C ^c   Szymanska, B ^a   Tronczynska, E ^a   Plucienniczak, A ^b   Selmaj, K ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Genetic polymorphism; Genetic susceptibility; LTa; MS; TNF

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; DNA SEQUENCE; GENE FREQUENCY; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALLELES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENOTYPE; HLA-DR2 ANTIGEN; HUMANS; LYMPHOTOXIN-ALPHA; MULTIPLE SCLEROSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECURRENCE; SEQUENCE ANALYSIS, DNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032522204     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00255-5     Document Type: Article

References (50)

1. Aggarwal B.B., Natarajan K. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:1996;93-124.
2. Baker D., Butler D., Scallon B.J., O'Neill J.K., Turk J.L., Feldmann M. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24:1994;2040-2204.
3. Begovich A.B., McClure G.R., Suraj V.C., Helmuth R.C., Fildes N., Bugawan T.L., Erlich H.A., Klitz W. Polymorphism, recombination, and linkage disequilibrium within the HLA Class II region. J. Immunol. 148:1992;249-258.
4. Bettinotti M.P., Hartung H., Deicher H., Messer G., Keller E., Weiss E.H., Albert E.D. Polymorphism of tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics. 37:1993;449-454.
5. Braun N., Michel U., Ernst B.P., Metzner R., Bitsch A., Weber F., Rieckmann P. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci. Lett. 215:1996;75-78.
6. Brinkman B.M.N., Zuijdgeest D., Kaijzel E.L., Breedveld F.C., Verweij C.L. Relevance of tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFα gene regulation. J. Inflamm. 46:1996;32-41.
7. Cabrera M., Shaw M.A., Sharples C., Wiliams H., Castes M., Guvit J., Blackwell J.M. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182:1995;1259-1264.
8. Compston D.A., Batchelor J.R., Earl C.J., McDonald W.I. Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain. 101:1978;495-511.
9. Dawkins R.L., Spies T., Strominger J.L., Hansen J.A. Some disease-associated ancestral haplotype carry a polymorphism of TNF. Hum. Immunol. 26:1989;91-94.
10. Ebers G.C., Sadovnick A.D. The role of genetic factors in multiple sclerosis susceptibility. J. Neuroimmunol. 54:1994;1-17.
11. Ebers G.C., Kukay K., Bulman D.E.et al. A full genome search in multiple sclerosis. Nat. Genet. 13:1996;472-476.
12. Epplen C., Jackel S., Santos E.J.M., D'Souza M., Poehlau D., Dotzauer B., Sindern E., Haupts M., Rude K.-P., Weber F., Stover J., Poser S., Gehler W., Malin J.-P., Przuntek H., Epplen J.T. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann. Neurol. 41:1997;341-352.
13. Erlich H., Bugawan T., Begovich A.B., Scharf S., Griffith R., Saiki R., Higuchi R., Walsh P.S. HLA-DR, DQ and DP typing using PCR amplification and immobilised probes. Eur. J. Immunogenet. 18:1991;33-55.
14. Fugger L., Morling N., Sanberg-Wollheim M., Ryder L.P., Svejgaard A. Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis. J. Neuroimmunol. 27:1990;85-86.
15. Gustincich S., Manfiolett G., Del Sal G., Schneider C., Carnici P. A fast method for high-quality genomic DNA extraction from whole human blood. BioTechniques. 11:1991;298-302.
16. Hafler D.A., Weiner H.L. MS: a CNS and systemic autoimmune disease. Immunol. Today. 10:1989;104-107.
17. Hauser S.L., Doolittle T.H., Lincoln R., Brown R.H., Dinarello C.A. Cytokine accumulation in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology. 40:1990;1739-1739.
18. He B., Navikas V., Lundahl J., Sodestrom M., Hillert J. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J. Neuroimmunol. 63:1995;143-147.
19. Huizinga T.W.J., Westendorp R.G.J., Bollen E.L.E.M., Keijsers V., Brinkman B.M.N., Langermans J.A.M., Breedveld F.C., Verweij C.L., van de Gaer L., Dams L., Crusius J.B.A., Garcia-Gonzales A., van Oosten B.W., Polman C.H., Pena A.S. TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J. Neuroimmunol. 72:1997;149-153.
20. Ihonen J., Merivelon H., Reijonen H., Khip M., Akerbom H.K., Pociot F., Nerup J. Tumor necrosis factor-β gene RFLP alleles in Finnish IDDM haplotypes. Scand. J. Immunol. 36:1992;779-783.
21. Imamura K., Suzumura A., Hayashi F., Marunouchi T. Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients. Acta Neurol. Scand. 87:1993;281-285.
22. Klinkert W.E.F., Bauerle H., Kojima K., Lesslauer W., Rinner W., Lassmann H., Wekerle H. Recombinant human TNF-α receptor-immunoglobulin fusion protein prevents EAE in Lewis rats. Eur. Cytokine Netw. 7:1996;296.
23. Kobayashi Y., Miyomotu D., Asada M., Obinata M., Osawa T. Cloning and expression of human lymphotoxin mRNA derived from a human T cell hydrydoma. J. Biochem. 100:1986;727-730.
24. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
25. Liblau R.S., Singer S.M., McDevitt H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:1995;34-38.
26. McDonald W.I., Batchelor J.R., Francis D.A. The immunogenetics of multiple sclerosis. Trends Neurol. Sci. 10:1994;369-371.
27. McGuire W., Hill A.V.S., Allsopp C.E.M., Greenwood B.M., Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-511.
28. Medcraft J., Hitmann G.A., Sachs J.A., Whichelow C.E., Raufat I., Moore R.H. Autoimmune renal disease and tumor necrosis factor β gene polymorphism. Clin. Nephrol. 40:1993;63-68.
29. Messer G., Spengler H., Jung M.C., Honald G., Blomer K., Pape G.R., Riethmuller G., Weiss E.H. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino-acid in position 26 and a reduced level of the TNF-β production. J. Exp. Med. 173:1991;209-219.
30. Messer G., Kick G., Ranki A., Koskimies S., Reumala T., Meurer M. Polymorphism of tumor necrosis factor genes in patients with dermatitis herpetiformis. Dermatology. 189:1994;135-137. Suppl.
31. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtelotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
32. Raine C.S. Multiple sclerosis: TNF revisited, with promise. Nat. Med. 1:1995;244-248.
33. Rentos M., Nikolau C., Rombos A., Voumvourakis V., Sagditsa I., Papageorgiou C. Tumor necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies. J. Neurol. 243:1996;165-170.
34. Rieckmann P., Albert M., Kitze B., Weber T., Tumani H., Broocks A., Lüer W., Poser S. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology. 44:1994;1523-1526.
35. Roth M.P., Nogueira L., Coppin H., Clanet M., Clayton J., Cambon-Thomsen A. Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA. J. Neuroimmunol. 51:1994;93-99.
36. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenhold E.G., Grunnot M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
37. Rudick R.A., Ransahoff R.M. Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity. Arch. Neurol. 49:1992;265-270.
38. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., Comston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13:1996;464-468.
39. Selmaj K.W. The role of cytokines in inflammatory conditions of the central nervous system. Semin. Neurosci. 4:1992;221-229.
40. Selmaj K., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;333-346.
41. Selmaj K., Raine C.S., Cannella B., Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:1991;949-954.
42. Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:1991;694-700.
43. Selmaj K., Papierz W., Glabinski A., Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56:1995;135-141.
44. Sharief M.K., Henteges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. New Engl. J. Med. 325:1991;467-472.
45. Steinman L. Escape from 'horror autotoxicus': pathogenesis and treatment of autoimmune disease. Cell. 80:1995;7-10.
46. The Multiple Sclerosis Genetics Group A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:1996;469-471.
47. Trede N.S., Tsytsykova A.V., Chatika T., Goldfeld A.E., Geha R.S. Transcriptional activation of the human TNFα promoter by superantigen in human monocytic cells. J. Immunol. 155:1995;902-908.
48. Wilson A.G., Symons J.A., McDowell T.L., diGiovine F.S., Duff G.W. Effects of a tumor necrosis factor (TNF-alpha) promoter base transition on transcriptional activity. Br. J. Rheumatol. 33:1994;89-92.
49. Wilson A.G., Gordon C., di Giovine F.S., de Vries N., van de Putte L.B., Emery P., Duff G.W. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur. J. Immunol. 24:1994;191-195.
50. Zipp F., Weber F., Huber S., Sotgiu S., Czlonkowska A., Holler E., Albert E., Weiss E.H., Wekerle H., Hohlfeld R. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-α by HLA-DR2+ T cells. Ann. Neurol. 38:1995;723-730.